These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Partnerships in cardiovascular disease prevention. Wilson E Can J Cardiol; 1999 Dec; 15 Suppl G():117G-9G. PubMed ID: 10692672 [No Abstract] [Full Text] [Related]
4. [Pay for disease or invest in health?]. Rydén L; Andersen K; Gyberg V; Mellbin L Lakartidningen; 2012 Sep 5-11; 109(36):1535-9. PubMed ID: 23016235 [No Abstract] [Full Text] [Related]
5. The European Heart Health Charter: towards a healthier Europe. Rydén L; Martin J; Volqvartz S Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):355-6. PubMed ID: 17568232 [No Abstract] [Full Text] [Related]
6. Promoting heart health: building on the European Council conclusions from Cork. Shelley E Eur J Cardiovasc Prev Rehabil; 2004 Dec; 11(6):453-5. PubMed ID: 15580053 [No Abstract] [Full Text] [Related]
7. Worksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart Association. Carnethon M; Whitsel LP; Franklin BA; Kris-Etherton P; Milani R; Pratt CA; Wagner GR; ; ; ; Circulation; 2009 Oct; 120(17):1725-41. PubMed ID: 19794121 [No Abstract] [Full Text] [Related]
8. The challenge for preventive cardiology. Kotseva K; Wood D Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431 [No Abstract] [Full Text] [Related]
9. [Who should implement cardiovascular prevention and health promotion?]. Vanuzzo D; Pinna C; Giampaoli S; Pilotto L; Brianti G; Coppola N; Di Lenarda A; Antonini-Canterin F; Miglio G; Zanier L; Canciani L; Paduano R; Battigelli D; Samani F; Brusaferro S G Ital Cardiol (Rome); 2015 May; 16(5):284-8. PubMed ID: 25994464 [No Abstract] [Full Text] [Related]
10. The current role of ACE-inhibitors for secondary prevention in cardiovascular disease; from pathogenesis to clinical practice. Voors AA; van Veldhuisen DJ; van Gilst WH Cardiovasc Drugs Ther; 2006 Feb; 20(1):69-73. PubMed ID: 16619108 [No Abstract] [Full Text] [Related]
11. Heart of the matter. Riley C; Felvus J; Warner M Health Serv J; 1991 Sep; 101(5268):21-3. PubMed ID: 10114462 [TBL] [Abstract][Full Text] [Related]
12. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Yusuf S; Wood D; Ralston J; Reddy KS Lancet; 2015 Jul; 386(9991):399-402. PubMed ID: 25892680 [No Abstract] [Full Text] [Related]
13. [Should general health surveys be offered to the population?]. Olivarius Nde F; Vass M; Drivsholm TB; Hindsberger C Ugeskr Laeger; 2002 Sep; 164(36):4199-200; author reply 4200-1. PubMed ID: 12362842 [No Abstract] [Full Text] [Related]
14. CardioPulse: Prevention of global cardiovascular disease. Yusuf S; Wood D; Ralston J; Reddy KS Eur Heart J; 2016 Feb; 37(6):505-7. PubMed ID: 27458620 [No Abstract] [Full Text] [Related]
15. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary. Expert Panel on Dyslipidemia Atherosclerosis; 2014 Feb; 232(2):410-3. PubMed ID: 24468156 [No Abstract] [Full Text] [Related]
16. [Recommendations of National Team of Cardiologic and Oncologic Supervision on cardiologic safety of patients with breast cancer. The prevention and treatment of cardiovascular complications in breast cancer. The Task Force of National Consultants in Cardiology and Clinical Oncology for the elaboration of recommendations of cardiologic proceeding with patients with breast cancer]. Opolski G; Krzakowski M; Szmit S; Banach J; Chudzik M; Cygankiewicz I; Drożdż J; Filipiak KJ; Grabowski M; Kaczmarek K; Kochman J; Lewek J; Maciejewski M; Miśkiewicz Z; Niwińska A; Pieńkowski T; Piestrzeniewicz K; Sinkiewicz W; Wranicz JK; Zawilska K; Kardiol Pol; 2011; 69(5):520-30. PubMed ID: 21594854 [No Abstract] [Full Text] [Related]
17. Principles for national and regional guidelines on cardiovascular disease prevention. Smith S; Voûte J; Fuster V Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):461. PubMed ID: 16932757 [No Abstract] [Full Text] [Related]
18. Cardiovascular Update: Risk, Guidelines, and Recommendations. Pearson T Workplace Health Saf; 2015 Sep; 63(9):376-80. PubMed ID: 26156147 [TBL] [Abstract][Full Text] [Related]
19. Representation of women in randomized clinical trials of cardiovascular disease prevention. Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular diseases, risk factors and barriers in their prevention in Croatia. Dzakula A; Sogorić S; Polasek O; Jurisa A; Andrić A; Radaković N; Todorović G Coll Antropol; 2009 Apr; 33 Suppl 1():87-92. PubMed ID: 19563152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]